Adma Biologics (ADMA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Sales | 56,914 | 49,982 | 41,090 | 33,905 | 29,103 |
| Cost of Goods | 40,401 | 35,805 | 31,434 | 26,136 | 25,441 |
| Gross Profit | 16,513 | 14,177 | 9,657 | 7,769 | 3,662 |
| Operating Expenses | 17,727 | 21,040 | 19,407 | 17,080 | 18,918 |
| Operating Income | -813 | -6,059 | -9,317 | -9,175 | -14,815 |
| Interest Expense | 6,115 | 5,737 | 5,580 | 4,573 | 3,389 |
| Other Income | 139 | -437 | -2 | -17 | -6,804 |
| Pre-tax Income | -6,789 | -12,232 | -14,900 | -13,765 | -25,008 |
| Net Income Continuous | -6,789 | -12,232 | -14,900 | -13,765 | -25,008 |
| Net Income | $-6,789 | $-12,232 | $-14,900 | $-13,765 | $-25,008 |
| EPS Basic Total Ops | -0.03 | -0.05 | -0.08 | -0.07 | -0.13 |
| EPS Basic Continuous Ops | -0.03 | -0.06 | -0.08 | -0.07 | -0.13 |
| EPS Diluted Total Ops | -0.03 | -0.05 | -0.08 | -0.07 | -0.13 |
| EPS Diluted Continuous Ops | -0.03 | -0.06 | -0.08 | -0.07 | -0.13 |
| EBITDA(a) | $1,672 | $-3,664 | $-6,509 | $-7,144 | $-12,676 |